Exchange Only. The Holder is a current holder of Securities and has not provided any consideration to the Company for the Preferred Stock received in the Exchange other than the Securities. The Holder understands that: (i) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and the Preferred Stock issued in the Exchange may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or (C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.
Appears in 1 contract
Sources: Exchange Agreement (OncBioMune Pharmaceuticals, Inc)
Exchange Only. The Holder Investor is a current holder of Securities and has not provided any consideration to the Company for the Preferred Stock Series C-2 received in the Exchange other than the Securities. The Holder Each Investor understands that: (i) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and the Preferred Stock Series C-2 issued in the Exchange may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or (C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.
Appears in 1 contract
Sources: Exchange Agreement (OncBioMune Pharmaceuticals, Inc)
Exchange Only. The Holder Investor is a current holder of Securities and has not provided any consideration to the Company for the Preferred Stock Series C-1 received in the Exchange other than the Securities. The Holder Each Investor understands that: (i) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and the Preferred Stock Series C-1 issued in the Exchange may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or (C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.
Appears in 1 contract
Sources: Exchange Agreement (OncBioMune Pharmaceuticals, Inc)
Exchange Only. The Holder is a current holder of Securities and has not provided any consideration to the Company for the Preferred Stock Shares received in the Exchange other than the Securities. The Holder understands that: (i) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and the Preferred Stock Shares issued in the Exchange may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or (C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.
Appears in 1 contract
Exchange Only. The Holder is a current holder of Securities and has not provided any consideration to the Company for the Preferred Stock Exchanged Securities received in the Exchange other than the Securities. The Holder understands that: (i) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and the Preferred Stock Exchanged Securities issued in the Exchange may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or (C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.
Appears in 1 contract